Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gavin

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guidelineDawn L Hershman, Christina Lacchetti, Robert H Dworkin, et al.
The Lancet. Neurology|October 23, 2021
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick Gavin Kehoe, Nicholas Turner, Beth Howden, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBernard Fongang, Yannick Joel Wadop Ngouongo, Sami Heikkinen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer's Disease in European Populations: Development and ValidationBayram Cevdet Akdeniz, Shahram Bahrami, Espen Hagen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
<i>APOE</i> stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's diseaseJesper Qvist Thomassen, Leonard Hampton, Brittany Ulms, et al.
Molecular Psychiatry|December 5, 2024
X-chromosome-wide association study for Alzheimer's diseaseJulie Le Borgne, Lissette Gomez, Sami Heikkinen, et al.
Nature Communications|June 8, 2021
Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guidelineDawn L Hershman, Christina Lacchetti, Robert H Dworkin, et al.
The Lancet. Neurology|October 23, 2021
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick Gavin Kehoe, Nicholas Turner, Beth Howden, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBernard Fongang, Yannick Joel Wadop Ngouongo, Sami Heikkinen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer's Disease in European Populations: Development and ValidationBayram Cevdet Akdeniz, Shahram Bahrami, Espen Hagen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
<i>APOE</i> stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's diseaseJesper Qvist Thomassen, Leonard Hampton, Brittany Ulms, et al.
Molecular Psychiatry|December 5, 2024
X-chromosome-wide association study for Alzheimer's diseaseJulie Le Borgne, Lissette Gomez, Sami Heikkinen, et al.
Nature Communications|June 8, 2021
Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Pageof 7